US Stock MarketDetailed Quotes
WINT Windtree Therapeutics
- 4.9400
- +0.6100+14.09%
Close May 3 16:00 ET
- 4.9000
- -0.0400-0.81%
Pre 08:02 ET
2.52MMarket Cap-52P/E (TTM)
5.5399High4.3150Low125.25KVolume4.3200Open4.3300Pre Close615.15KTurnover27.75%Turnover RatioLossP/E (Static)510.18KShares35.100052wk High0.74P/B2.23MFloat Cap4.180052wk Low--Dividend TTM451.34KShs Float3341518.3292Historical High--Div YieldTTM28.29%Amplitude4.1800Historical Low4.9110Avg Price1Lot Size
About Windtree Therapeutics Company
Windtree Therapeutics, Inc. is a clinical-stage biopharmaceutical and medical device company engaged in the development of novel therapeutics intended to address significant unmet medical needs in important acute care markets. It focuses on the treatment of acute cardiovascular and acute pulmonary diseases. The company was founded by Evan Myrianthopoulos and James S. Kuo on November 6, 1992 and is headquartered in Warrington, PA.
Company Profile
SymbolWINT
Company NameWindtree Therapeutics
Listing DateAug 8, 1995
Issue Price3.50
Founded1992
CEOMr. Craig E. Fraser
MarketNASDAQ
Employees15
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address2600 Kelly Road,Suite 100
CityWarrington
ProvincePennsylvania
CountryUnited States of America
Zip Code18976-3622
Phone1-215-488-9300
Websitehttp://www.windtreetx.com
Company Executives
- Name
- Position
- Salary
- Craig E. Fraser
- Chairman of the Board, President, Chief Executive Officer and Interim Principal Financial Officer
- 940.91K
- Dr. Steven G. Simonson, M.D.
- Senior Vice President and Chief Medical Officer
- 600.01K
- Eric Curtis
- Senior Vice President and Chief Operating Officer
- --
- Dr. Robert Andrew Donald Scott, M.D.
- Independent Director
- 60.34K
- Dr. Mark Strobeck, PhD
- Independent Director
- --
- Leslie J. Williams
- Lead Independent Director
- 59.84K
- Daniel E. Geffken, M.B.A.
- Independent Director
- 65.34K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
